Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider

Overview of attention for article published in Frontiers in Oral Health, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,543 followers.

Open Access UCL Research: Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider - UCL Discovery https://t.co/e1b3KjNLAG

23 Sep 2022

Reply Repost Favourite

RT @tango_ballet: orofacial-irAEのReview (2022.8) ①口腔粘膜病変(紅斑, 潰瘍): Ddx 口腔扁平苔癬-like, 多形滲出性紅斑-like, 尋常性天疱瘡, SJS/TENなど ②ドライマウス: Ddx Sjogren-lik…

15 Sep 2022

Reply Repost Favourite

orofacial-irAEのReview (2022.8) ①口腔粘膜病変(紅斑, 潰瘍): Ddx 口腔扁平苔癬-like, 多形滲出性紅斑-like, 尋常性天疱瘡, SJS/TENなど ②ドライマウス: Ddx Sjogren-like についての記載がメイン. ①にときどき遭遇します. とても参考になりました. https://t.co/Ukgkz2JUOa

15 Sep 2022

Reply Repost Favourite

New research: Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider https://t.co/eH3eoIhb4A #oralhealth

11 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.